- Filed
- Aug 28, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q2 2026 · Jul 31, 2025 | 22.57M sh |
| Shares Diluted | Q2 2026 · Jul 31, 2025 | 22.48M sh |
| Shares Diluted | Q2 2026 · Jul 31, 2024 | 22.66M sh |
| Shares Diluted | Q2 2026 · Jul 31, 2024 | 22.67M sh |
| Stock Repurchased | Q2 2026 · Jul 31, 2025 | $1.59M |
| Stock Repurchased | Q2 2026 · Jul 31, 2024 | $1.09M |
| Dividends Paid | Q2 2026 · Jul 31, 2025 | $15.56M |
| Dividends Paid | Q2 2026 · Jul 31, 2024 | $15.55M |
| Capex | Q2 2026 · Jul 31, 2025 | $2.83M |
| Capex | Q2 2026 · Jul 31, 2024 | $3.91M |
| Operating Cash Flow | Q2 2026 · Jul 31, 2025 | −$11.02M |
| Operating Cash Flow | Q2 2026 · Jul 31, 2024 | −$35.91M |
| Cash And Equivalents | Q2 2026 · Jul 31, 2025 | $180.49M |
| Cash And Equivalents | Q2 2026 · Jan 31, 2025 | $208.5M |
| Cash And Equivalents | Q2 2026 · Jul 31, 2024 | $198.25M |
| Stockholders Equity | Q2 2026 · Jul 31, 2025 | $489.91M |
| Stockholders Equity | Q2 2026 · Jan 31, 2025 | $481.33M |
| Stockholders Equity restated | Q2 2026 · Jul 31, 2024 | $492.04M |
| Current Liabilities | Q2 2026 · Jul 31, 2025 | $131.42M |
| Current Liabilities | Q2 2026 · Jan 31, 2025 | $112.96M |
| Current Liabilities restated | Q2 2026 · Jul 31, 2024 | $114.39M |
| Total Liabilities | Q2 2026 · Jul 31, 2025 | $256.48M |
| Total Liabilities | Q2 2026 · Jan 31, 2025 | $245.65M |
| Total Liabilities restated | Q2 2026 · Jul 31, 2024 | $248.07M |
| Current Assets | Q2 2026 · Jul 31, 2025 | $516.19M |
| Current Assets | Q2 2026 · Jan 31, 2025 | $489.94M |
| Current Assets restated | Q2 2026 · Jul 31, 2024 | $507.23M |
| Total Assets | Q2 2026 · Jul 31, 2025 | $748.72M |
| Total Assets | Q2 2026 · Jan 31, 2025 | $729.23M |
| Total Assets restated | Q2 2026 · Jul 31, 2024 | $742.48M |
| Eps Diluted | Q2 2026 · Jul 31, 2025 | $0.13 |
| Eps Diluted | Q2 2026 · Jul 31, 2025 | $0.20 |
| Eps Diluted restated | Q2 2026 · Jul 31, 2024 | $0.15 |
| Eps Diluted restated | Q2 2026 · Jul 31, 2024 | $0.24 |
| Eps Basic | Q2 2026 · Jul 31, 2025 | $0.13 |
| Eps Basic | Q2 2026 · Jul 31, 2025 | $0.20 |
| Eps Basic restated | Q2 2026 · Jul 31, 2024 | $0.16 |
| Eps Basic restated | Q2 2026 · Jul 31, 2024 | $0.25 |
| Sga Expense | Q2 2026 · Jul 31, 2025 | $83.56M |
| Sga Expense | Q2 2026 · Jul 31, 2025 | $154.62M |
| Sga Expense restated | Q2 2026 · Jul 31, 2024 | $82.61M |
| Sga Expense restated | Q2 2026 · Jul 31, 2024 | $153.41M |
| Net Income | Q2 2026 · Jul 31, 2025 | $2.99M |
| Net Income | Q2 2026 · Jul 31, 2025 | $4.41M |
| Net Income restated | Q2 2026 · Jul 31, 2024 | $3.47M |
| Net Income restated | Q2 2026 · Jul 31, 2024 | $5.48M |
| Operating Income | Q2 2026 · Jul 31, 2025 | $4.01M |
| Operating Income | Q2 2026 · Jul 31, 2025 | $4.3M |
| Operating Income restated | Q2 2026 · Jul 31, 2024 | $2.64M |
| Operating Income restated | Q2 2026 · Jul 31, 2024 | $4.76M |
| Gross Profit | Q2 2026 · Jul 31, 2025 | $87.57M |
| Gross Profit | Q2 2026 · Jul 31, 2025 | $158.92M |
| Gross Profit restated | Q2 2026 · Jul 31, 2024 | $85.25M |
| Gross Profit restated | Q2 2026 · Jul 31, 2024 | $158.17M |
| Cost Of Revenue | Q2 2026 · Jul 31, 2025 | $74.26M |
| Cost Of Revenue | Q2 2026 · Jul 31, 2025 | $134.68M |
| Cost Of Revenue restated | Q2 2026 · Jul 31, 2024 | $71.75M |
| Cost Of Revenue restated | Q2 2026 · Jul 31, 2024 | $133.21M |
| Revenue | Q2 2026 · Jul 31, 2025 | $161.83M |
| Revenue | Q2 2026 · Jul 31, 2025 | $293.6M |
| Revenue restated | Q2 2026 · Jul 31, 2024 | $157M |
| Revenue restated | Q2 2026 · Jul 31, 2024 | $291.38M |